First American Trust FSB Takes Position in Xylem Inc. (NYSE:XYL)

First American Trust FSB purchased a new stake in Xylem Inc. (NYSE:XYL - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 34,694 shares of the industrial products company's stock, valued at approximately $3,968,000.

Other institutional investors also recently modified their holdings of the company. Bruce G. Allen Investments LLC bought a new stake in shares of Xylem in the fourth quarter valued at about $27,000. Coppell Advisory Solutions LLC bought a new stake in shares of Xylem in the second quarter valued at about $45,000. KB Financial Partners LLC bought a new stake in Xylem during the first quarter worth about $42,000. ST Germain D J Co. Inc. bought a new stake in Xylem during the second quarter worth about $46,000. Finally, NBC Securities Inc. bought a new stake in Xylem during the third quarter worth about $38,000. 87.96% of the stock is currently owned by institutional investors.

Xylem Stock Performance

Shares of Xylem stock traded down $0.82 on Monday, hitting $127.29. The stock had a trading volume of 968,617 shares, compared to its average volume of 1,143,641. Xylem Inc. has a twelve month low of $87.59 and a twelve month high of $130.86. The business's 50 day moving average is $126.62 and its two-hundred day moving average is $111.64. The company has a quick ratio of 1.30, a current ratio of 1.76 and a debt-to-equity ratio of 0.22. The stock has a market cap of $30.86 billion, a price-to-earnings ratio of 46.80, a price-to-earnings-growth ratio of 2.55 and a beta of 1.10.

Xylem (NYSE:XYL - Get Free Report) last posted its earnings results on Tuesday, February 6th. The industrial products company reported $0.99 EPS for the quarter, beating the consensus estimate of $0.96 by $0.03. Xylem had a return on equity of 9.65% and a net margin of 8.27%. The company had revenue of $2.12 billion for the quarter, compared to the consensus estimate of $2.05 billion. During the same quarter in the prior year, the business earned $0.92 earnings per share. The firm's revenue for the quarter was up 40.6% on a year-over-year basis. Analysts forecast that Xylem Inc. will post 4.13 EPS for the current year.

Xylem Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, March 20th. Stockholders of record on Wednesday, February 21st were given a $0.36 dividend. This is an increase from Xylem's previous quarterly dividend of $0.33. The ex-dividend date was Tuesday, February 20th. This represents a $1.44 annualized dividend and a dividend yield of 1.13%. Xylem's dividend payout ratio is presently 52.94%.

Insider Buying and Selling

In related news, SVP Franz Cerwinka sold 2,408 shares of the stock in a transaction that occurred on Thursday, February 8th. The stock was sold at an average price of $121.79, for a total transaction of $293,270.32. Following the sale, the senior vice president now owns 11,750 shares of the company's stock, valued at $1,431,032.50. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In related news, SVP Franz Cerwinka sold 2,408 shares of the stock in a transaction that occurred on Thursday, February 8th. The stock was sold at an average price of $121.79, for a total transaction of $293,270.32. Following the sale, the senior vice president now owns 11,750 shares of the company's stock, valued at $1,431,032.50. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CAO Geri-Michelle Mcshane sold 1,000 shares of the stock in a transaction that occurred on Tuesday, February 20th. The stock was sold at an average price of $122.89, for a total value of $122,890.00. Following the sale, the chief accounting officer now directly owns 2,935 shares in the company, valued at approximately $360,682.15. The disclosure for this sale can be found here. 0.27% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

Several analysts recently issued reports on XYL shares. Robert W. Baird upped their target price on Xylem from $141.00 to $148.00 and gave the stock an "outperform" rating in a report on Thursday, March 21st. Royal Bank of Canada upped their target price on Xylem from $140.00 to $145.00 and gave the stock an "outperform" rating in a report on Wednesday, February 7th. BNP Paribas started coverage on Xylem in a report on Tuesday, March 12th. They set an "outperform" rating and a $150.00 target price on the stock. Raymond James upgraded Xylem from an "underperform" rating to a "market perform" rating in a report on Thursday, January 4th. Finally, Stifel Nicolaus upped their target price on Xylem from $136.00 to $150.00 and gave the stock a "buy" rating in a report on Wednesday, February 7th. Four investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company's stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $135.44.

Xylem Company Profile

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.